Siemens Healthineers has officially commenced construction on a new R&D and manufacturing facility in Shenzhen, China with a total investment value exceeding $137 million (1 billion RMB) and is scheduled to be operational by the end of 2027.

The new site — spanning 63,000 square meters with a total construction area of 98,000 square meters — will complement the imaging OEM's existing Shenzhen base by implementing a "dual-site operation" model, forming the Siemens Healthineers (Shenzhen) Innovation Industrial Park. Once completed, the new facility will triple the operational scale of the Shenzhen base, enhancing its capabilities in R&D, manufacturing, and talent development.

Key functions of the new facility will include the development and production of angiography systems and components for MR, including DryCool superconducting magnets, which cut the helium requirement from 1,500 liters to less than one liter and can be used in a closed circuit system without the need for a quench pipe.
The base will also foster industry-university collaboration within the Xili Lake International Science and Education City to bolster local innovation and talent development.

"China has always been a source of growth and innovation for Siemens Healthineers," said Tao Lin, a member of the board of management. "This new base underscores our commitment to participating in China's medical innovation ecosystem and supporting the 'Healthy China' strategy while fostering global collaboration."

Since its establishment in 2002, the Shenzhen base has grown into one of Siemens Healthineers’ largest R&D and production hubs outside Germany, with over 9,000 MR systems produced and a localization rate exceeding 80%. In 2024, the Shenzhen team achieved NMPA approval of the domestically produced 7T MR system, the MAGNETOM Terra.X.

In 2024, Siemens announced it was investing $314 million (£250 million) in a new 56,000 square-meter facility in North Oxfordshire, U.K., to design and manufacture superconducting magnets for MR scanners requiring dramatically less helium than conventional systems.

In 2023, the company invested $85 million to expand production of photon-counting CT detectors in Forchheim, Germany.

MRI Homepage